Keybanc Maintains Overweight on Colfax, Lowers Price Target to $52
Keybanc analyst Jeffrey Hammond maintains Colfax (NYSE:CFX) with a Overweight and lowers the price target from $60 to $52.
Colfax Earnings Perspective: Return On Capital Employed
Colfax (NYSE:CFX) brought in sales totaling $1.02 billion during Q4 according to data provided by Benzinga Pro. However, earnings decreased 101.94%, resulting in a loss of $521.00 thousand.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's trading, 98 companies set new 52-week lows.
What 4 Analyst Ratings Have To Say About Colfax
Over the past 3 months, 4 analysts have published their opinion on Colfax (NYSE:CFX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Colfax Q4 EPS $0.59 Beats $0.57 Estimate, Sales $1.02B Beat $1.01B Estimate
Colfax (NYSE:CFX) reported quarterly earnings of $0.59 per share which beat the analyst consensus estimate of $0.57 by 3.51 percent. This is a 15.69 percent increase over earnings of $0.51 per share from the same period
Earnings Scheduled For February 22, 2022
Companies Reporting Before The Bell
• Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million.
Seaport Global Downgrades Colfax to Neutral
Seaport Global analyst Walter Liptak downgrades Colfax (NYSE:CFX) from Buy to Neutral.
Where Colfax Stands With Analysts
Over the past 3 months, 4 analysts have published their opinion on Colfax (NYSE:CFX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.